<DOC>
	<DOCNO>NCT00622492</DOCNO>
	<brief_summary>Rationale : Persistent pulmonary hypertension newborn ( PPHN ) life threaten disease high mortality rate . Extracorporeal Membrane Oxygenation ( ECMO ) veno-arterial ( V-A ) veno-venous ( V-V ) cannulation provide last treatment option . Differences circulatory change V-A V-V ECMO concern course PPHN organ perfusion know . Independent underlying disease , course ECMO run ( system ) may differ lot . Impairment pulmonary renal function oedema frequently see . Mechanisms may play role well understood yet . A good understanding hemodynamic change systemic pulmonary circulation treatment PPHN ECMO well consecutive change organ perfusion function help develop rationalistic treatment strategy accelerate recovery normal neonatal circulation shorten ECMO treatment . This reveal positive effect patient well favourable effect economic aspect intensive treatment . Primary objective : I.Evaluation change pulmonary systemic circulation VV- ECMO treatment difference V-V- V-A ECMO Secondary objective : II.Evaluation change cerebral , renal mesenterial organ perfusion ECMO treatment difference V-V- V-A ECMO III.Evaluation hemodynamic change ECMO treatment relation renal function difference V-V- V-A ECMO IV.Evaluation BNP diagnostic parameter regard fluid homeostasis ECMO treatment difference V-V- V-A ECMO Study design : observational ; include two cohort . The first cohort consist group patient evaluate former study , exclusively treat V-A ECMO . The second cohort patient prospectively include patient receive V-V well V-A ECMO . A study period:2 half year . All consecutively admit patient ECMO treatment department neonatology RUNMC evaluate inclusion study . Study population : Inclusion : Newborn infant gestational age old 34 week reversible cause PPHN eligible ECMO treatment . Exclusion : Newborn infant congenital diaphragmatic hernia , congenital malformation post-cardiosurgery . Intervention : Standard treatment follow ECMO protocol department ; evaluation standard interval start directly cannulation ECMO 24 hour decannulation : registration hemodynamic variable , parameter organ perfusion use echocardiography Doppler sonography , blood urine sample registration physiological patient data . Main study parameters/endpoints : Assessment : Hemodynamic change pulmonary systemic circulation Secondary parameters/endpoints : Assessment : Changes cerebral , renal mesenterial blood flow , renal function relation hemodynamic change , BNP relation fluid homeostasis</brief_summary>
	<brief_title>Circulatory Changes During Venovenous ( VV ) - Venoarterial ( VA ) Extracorporeal Membrane Oxygenation ( ECMO )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Reversible cause PPHN Newborn infant Older 34 week gestational age Congenital diaphragmatic hernia Congenital malformation Postcardiosurgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>VV-ECMO</keyword>
	<keyword>VA-ECMO</keyword>
	<keyword>PPHN</keyword>
	<keyword>organ circulation</keyword>
</DOC>